101 related articles for article (PubMed ID: 18623291)
1. Application of metal-free triazole formation in the synthesis of cyclic RGD-DTPA conjugates.
van Berkel SS; Dirks A'; Meeuwissen SA; Pingen DL; Boerman OC; Laverman P; van Delft FL; Cornelissen JJ; Rutjes FP
Chembiochem; 2008 Jul; 9(11):1805-15. PubMed ID: 18623291
[TBL] [Abstract][Full Text] [Related]
2. In-depth evaluation of the cycloaddition--retro-Diels--Alder reaction for in vivo targeting with [(111)In]-DTPA-RGD conjugates.
Laverman P; Meeuwissen SA; van Berkel SS; Oyen WJ; van Delft FL; Rutjes FP; Boerman OC
Nucl Med Biol; 2009 Oct; 36(7):749-57. PubMed ID: 19720287
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes.
Dijkgraaf I; Rijnders AY; Soede A; Dechesne AC; van Esse GW; Brouwer AJ; Corstens FH; Boerman OC; Rijkers DT; Liskamp RM
Org Biomol Chem; 2007 Mar; 5(6):935-44. PubMed ID: 17340009
[TBL] [Abstract][Full Text] [Related]
4. Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation.
Thumshirn G; Hersel U; Goodman SL; Kessler H
Chemistry; 2003 Jun; 9(12):2717-25. PubMed ID: 12772286
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys).
Alves S; Correia JD; Gano L; Rold TL; Prasanphanich A; Haubner R; Rupprich M; Alberto R; Decristoforo C; Santos I; Smith CJ
Bioconjug Chem; 2007; 18(2):530-7. PubMed ID: 17373771
[TBL] [Abstract][Full Text] [Related]
6. Convenient solid-phase synthesis of diethylenetriaminepenta-acetic acid (DTPA)- conjugated cyclic RGD peptide analogues.
Wang W; McMurray JS; Wu Q; Campbell ML; Li C
Cancer Biother Radiopharm; 2005 Oct; 20(5):547-56. PubMed ID: 16248770
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands.
Salvati M; Cordero FM; Pisaneschi F; Melani F; Gratteri P; Cini N; Bottoncetti A; Brandi A
Bioorg Med Chem; 2008 Apr; 16(8):4262-71. PubMed ID: 18343671
[TBL] [Abstract][Full Text] [Related]
8. New potent and selective αvβ
Wu Z; Cheng X; Hong H; Zhao X; Zhou Z
Bioorg Med Chem Lett; 2017 May; 27(9):1911-1913. PubMed ID: 28351594
[TBL] [Abstract][Full Text] [Related]
9. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging.
Yu HM; Chen JH; Lin KL; Lin WJ
J Labelled Comp Radiopharm; 2015 Jun; 58(7):299-303. PubMed ID: 25997858
[TBL] [Abstract][Full Text] [Related]
11. Cyclic aza-peptide integrin ligand synthesis and biological activity.
Spiegel J; Mas-Moruno C; Kessler H; Lubell WD
J Org Chem; 2012 Jun; 77(12):5271-8. PubMed ID: 22582818
[TBL] [Abstract][Full Text] [Related]
12. Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.
Garanger E; Boturyn D; Coll JL; Favrot MC; Dumy P
Org Biomol Chem; 2006 May; 4(10):1958-65. PubMed ID: 16688341
[TBL] [Abstract][Full Text] [Related]
13. On-resin head-to-tail cyclization of cyclotetrapeptides: optimization of crucial parameters.
Alcaro MC; Sabatino G; Uziel J; Chelli M; Ginanneschi M; Rovero P; Papini AM
J Pept Sci; 2004 Apr; 10(4):218-28. PubMed ID: 15119594
[TBL] [Abstract][Full Text] [Related]
14. Macrocyclic templates for library synthesis of peptido-conjugates.
Zaretsky S; Tan J; Hickey JL; Yudin AK
Methods Mol Biol; 2015; 1248():67-80. PubMed ID: 25616326
[TBL] [Abstract][Full Text] [Related]
15. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of thioether building blocks into an alphavbeta3-specific RGD peptide: synthesis and biological activity.
Kelleman A; Mattern RH; Pierschbacher MD; Goodman M
Biopolymers; 2003; 71(6):686-95. PubMed ID: 14991678
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenesis activities of novel peptide complexes: mitochondria-disruptive 9mer peptides conjugated with the integrin alpha V beta 3-homing cyclic RGD motif.
Iwasaki T; Yamakawa M; Asaoka A; Kawano T; Ishibashi J
Biosci Biotechnol Biochem; 2012; 76(11):2044-8. PubMed ID: 23132564
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
Liu S
Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
[TBL] [Abstract][Full Text] [Related]
19. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies.
Pearson DA; Lister-James ; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Dean RT
J Med Chem; 1996 Mar; 39(7):1372-82. PubMed ID: 8691467
[TBL] [Abstract][Full Text] [Related]
20. Design of RGD-ATWLPPR peptide conjugates for the dual targeting of α
Thoreau F; Vanwonterghem L; Henry M; Coll JL; Boturyn D
Org Biomol Chem; 2018 Jun; 16(22):4101-4107. PubMed ID: 29774910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
